Publications by authors named "Sean P Curtis"

Claim this Profile
A
A Call To Action: Developing an Agile Global Regulatory Affairs Workforce for the Future.
Lina AlJuburi, Nicole Mahoney, Eddie Reilly, Amy Bertha, David C Isom, Sean P Curtis

Ther Innov Regul Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspective.
Andrew S Robertson, Nahid Latif, Imein Bousnina, Donna Boyce, Kevin Carl, Sean P Curtis

Nat Rev Drug Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK).
Cindy L J Weinstein, Paula Sliwinska-Stanczyk, Tomas Hála, Marina Stanislav, Anjela Tzontcheva, Sean P Curtis

Rheumatology (Oxford)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension.
Désirée van der Heijde, Maxime Dougados, Walter P Maksymowych, Gina Bergman, Sean P Curtis

Rheumatology (Oxford)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci.
Vinicius Tragante, Michael R Barnes, Santhi K Ganesh, Matthew B Lanktree, Wei Guo, Sean P Curtis

Am J Hum Genet· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.
Michael V Holmes, Leslie A Lange, Tom Palmer, Matthew B Lanktree, Kari E North, Sean P Curtis

Am J Hum Genet· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.
Narinder Rawal, Eugene Viscusi, Paul M Peloso, Harold S Minkowitz, Liang Chen, Sean P Curtis

BMC Musculoskelet Disord· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung eQTLs to help reveal the molecular underpinnings of asthma.
Ke Hao, Yohan Bossé, David C Nickle, Peter D Paré, Dirkje S Postma, Sean P Curtis

PLoS Genet· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loci influencing blood pressure identified using a cardiovascular gene-centric array.
Santhi K Ganesh, Vinicius Tragante, Wei Guo, Yiran Guo, Matthew B Lanktree, Sean P Curtis

Hum Mol Genet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs.
Henry Krum, Gary Swergold, Arnold Gammaitoni, Paul M Peloso, Steven S Smugar, Sean P Curtis

Cardiovasc Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study.
Eugene R Viscusi, Tara L Frenkl, Craig T Hartrick, Narinder Rawal, Henrik Kehlet, Sean P Curtis

Curr Med Res Opin· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
Richa Saxena, Clara C Elbers, Yiran Guo, Inga Peter, Tom R Gaunt, Sean P Curtis

Am J Hum Genet· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Christian T Ruff, David A Morrow, Peter Jarolim, Fang Ren, Charles F Contant, Sean P Curtis

J Rheumatol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
Matthew B Lanktree, Yiran Guo, Muhammed Murtaza, Joseph T Glessner, Swneke D Bailey, Sean P Curtis

Am J Hum Genet· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.
Henry Krum, Sean P Curtis, Amarjot Kaur, Hongwei Wang, Steven S Smugar

Eur J Heart Fail· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.
Henry Krum, Gary Swergold, Sean P Curtis, Amarjot Kaur, Hongwei Wang

J Hypertens· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.
Loren Laine, Lawrence Goldkind, Sean P Curtis, Laurine G Connors, Zhang Yanqiong

Am J Gastroenterol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.
Loren Laine, Sean P Curtis, Michael Langman, Dennis M Jensen, Byron Cryer

Gastroenterology· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo.
Christopher P Cannon, Cong Chen, Sean P Curtis, John Viscusi, Tuli Ahmed

Arch Drug Inf· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial.
Alan Matsumoto, Agustin Melian, Arvind Shah, Sean P Curtis

Curr Med Res Opin· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Loren Laine, Sean P Curtis, Byron Cryer, Amarjot Kaur, Christopher P Cannon

Lancet· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.
Herbert S B Baraf, Carlos Fuentealba, Maria Greenwald, Jan Brzezicki, Katherine O'Brien, Sean P Curtis

J Rheumatol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib.
Sean P Curtis, Amy T Ko, James A Bolognese, Paul F Cavanaugh, Alise S Reicin

Curr Med Res Opin· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Christopher P Cannon, Sean P Curtis, Garret A FitzGerald, Henry Krum, Amarjot Kaur

Lancet· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
Christopher P Cannon, Sean P Curtis, James A Bolognese, Loren Laine,

Am Heart J· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis